Document is current
Any future updates will be listed below
-
Authors
Kristensen, Jonas M.
Kjøbsted, Rasmus https://orcid.org/0000-0002-0628-4994
Larsen, Trine J.
Carl, Christian S. https://orcid.org/0000-0002-9551-5837
Hingst, Janne R.
Onslev, Johan https://orcid.org/0000-0002-5143-9377
Birk, Jesper B. https://orcid.org/0000-0001-9775-4789
Thorup, Anette
Steenberg, Dorte E.
Knudsen, Jonas R. https://orcid.org/0000-0002-5471-491X
Henriksen, Nicolai S. https://orcid.org/0009-0008-7647-5535
Needham, Elise J.
Halling, Jens F.
Gudiksen, Anders
Rundsten, Carsten F.
Hanghøj, Kristian E.
Stinson, Sara E. https://orcid.org/0000-0002-1491-9179
Hoier, Birgitte
Hansen, Camilla C. https://orcid.org/0000-0003-2839-6150
Jensen, Thomas E. https://orcid.org/0000-0001-6139-8268
Hellsten, Ylva https://orcid.org/0000-0002-2435-9558
Pilegaard, Henriette https://orcid.org/0000-0002-1071-0327
Grarup, Niels https://orcid.org/0000-0001-5526-1070
Olesen, Jesper
Humphrey, Sean J. https://orcid.org/0000-0002-2666-9744
James, David E. https://orcid.org/0000-0001-5946-5257
Pedersen, Michael L.
Richter, Erik A. https://orcid.org/0000-0002-6850-3056
Hansen, Torben https://orcid.org/0000-0001-8748-3831
Jørgensen, Marit E. https://orcid.org/0000-0001-8356-5565
Wojtaszewski, Jørgen F. P. https://orcid.org/0000-0001-8185-3408
-
Funding
Funding for this research was provided by:
Det Frie Forskningsråd (#8020 00288B, #5053 00095B, #7016 00386B)
Novo Nordisk Fonden (#NNF14OC0013057, #NNF17OC0028136, #NNF17SA0031406, #NNF14OC0013057, #NNF17OC0028136, #NNF17OC0028136)
Australian Research Council Laureate Fellowship
Novo Nordisk Foundation Center for Basic Metabolic Research (#NNF18CC0034900)
- License Information
-
More Information
Article History
Received: 3 November 2023
Accepted: 27 September 2024
First Online: 31 October 2024
Competing interests
: J.F.P.W. has ongoing collaborations with Pfizer Inc. and Novo Nordisk A/S unrelated to this study. M.E.J. has received research grants from AMGEN, AstraZeneca, Boehringer Ingelheim and Sanofi Aventis. M.E.J., B.H., J.R.H., D.E.S., J.M.K. and J.F.P.W. hold shares in Novo Nordisk A/S. J.M.K., J.R.H., J.F.H., D.E.K., K.E.H., N.G. and J.R.K. are currently employed by Novo Nordisk A/S. The other authors declare no competing interests.
